• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性胸膜间皮瘤的外科治疗:系统评价与证据总结

Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary.

作者信息

Maziak Donna E, Gagliardi Anna, Haynes Adam E, Mackay Jean A, Evans William K

机构信息

University of Ottawa, Ottawa Hospital, General Campus, 501 Smyth Road, Ottawa, Ont., Canada K1H 8L6.

出版信息

Lung Cancer. 2005 May;48(2):157-69. doi: 10.1016/j.lungcan.2004.11.003. Epub 2005 Jan 5.

DOI:10.1016/j.lungcan.2004.11.003
PMID:15829316
Abstract

UNLABELLED

An evidence summary was developed for the surgical management of adult patients with diffuse or localized malignant pleural mesothelioma. This evidence summary is based on a systematic search and review of the literature published between 1985 and February 2004. Relevant studies were identified, according to pre-determined criteria by the authors and methodologists. No randomized controlled trials comparing pleurectomy (PL) with extrapleural pneumonectomy (EPP) or comparing surgery with an alternative treatment were identified. Four comparative studies, seven non-comparative prospective studies, and 16 retrospective case series were identified that looked at PL, or EPP, or PL and EPP. Trial results were not pooled due to the heterogeneity of the treatments in the trials and the fact that no trials were randomized and none were designed to directly compare different treatments. External feedback was obtained from Ontario clinicians, and the provincial Lung Cancer Disease Site Group approved the review.

CONCLUSIONS

The role of surgery in the management of malignant pleural mesothelioma cannot be precisely defined as the lack of randomized controlled clinical trials makes it impossible to determine whether the use of EPP or PL improves survival or effectively palliates the symptoms of the disease. Future studies of the role of surgery in the treatment of mesothelioma should include evaluations of quality of life.

摘要

未标注

针对成年弥漫性或局限性恶性胸膜间皮瘤患者的手术治疗制定了一份证据总结。该证据总结基于对1985年至2004年2月间发表的文献进行的系统检索和综述。作者和方法学家根据预先确定的标准确定了相关研究。未发现比较胸膜切除术(PL)与胸膜外全肺切除术(EPP)或比较手术与替代治疗的随机对照试验。确定了四项比较研究、七项非比较性前瞻性研究和16项回顾性病例系列,这些研究涉及PL、EPP或PL和EPP。由于试验中治疗方法的异质性以及没有试验是随机的且没有试验旨在直接比较不同治疗方法这一事实,未对试验结果进行汇总。从安大略省的临床医生那里获得了外部反馈,省级肺癌疾病部位小组批准了该综述。

结论

由于缺乏随机对照临床试验,无法确定使用EPP或PL是否能提高生存率或有效缓解疾病症状,因此手术在恶性胸膜间皮瘤管理中的作用无法精确界定。未来关于手术在间皮瘤治疗中作用的研究应包括生活质量评估。

相似文献

1
Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary.恶性胸膜间皮瘤的外科治疗:系统评价与证据总结
Lung Cancer. 2005 May;48(2):157-69. doi: 10.1016/j.lungcan.2004.11.003. Epub 2005 Jan 5.
2
Radical multimodality therapy for malignant pleural mesothelioma.恶性胸膜间皮瘤的根治性多模态治疗
Cochrane Database Syst Rev. 2018 Jan 8;1(1):CD012605. doi: 10.1002/14651858.CD012605.pub2.
3
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.晚期恶性胸膜间皮瘤患者化疗的应用:一项系统评价与实践指南
J Thorac Oncol. 2006 Jul;1(6):591-601.
7
Inhaled mannitol for cystic fibrosis.吸入用甘露醇治疗囊性纤维化。
Cochrane Database Syst Rev. 2018 Feb 9;2(2):CD008649. doi: 10.1002/14651858.CD008649.pub3.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
10
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.

引用本文的文献

1
Impact of guideline therapy on survival of patients with stage I-III epithelioid mesothelioma.指南治疗对Ⅰ-Ⅲ期上皮样间皮瘤患者生存的影响。
J Thorac Dis. 2023 Dec 30;15(12):6661-6673. doi: 10.21037/jtd-23-1334. Epub 2023 Dec 26.
2
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma.中国恶性胸膜间皮瘤诊断与治疗专家共识。
Thorac Cancer. 2023 Sep;14(26):2715-2731. doi: 10.1111/1759-7714.15022. Epub 2023 Jul 17.
3
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma.
低剂量吉西他滨联合顺铂持续输注治疗不可切除恶性胸膜间皮瘤患者的疗效、安全性及成本最小化分析
Front Oncol. 2021 Apr 20;11:641975. doi: 10.3389/fonc.2021.641975. eCollection 2021.
4
Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.胸膜剥脱术/去皮质术与胸膜外全肺切除术:关键抉择
J Thorac Dis. 2018 Jan;10(Suppl 2):S390-S394. doi: 10.21037/jtd.2018.01.116.
5
Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.恶性胸膜间皮瘤的化疗治疗:一段艰难的历程。
J Thorac Dis. 2018 Jan;10(Suppl 2):S304-S310. doi: 10.21037/jtd.2017.10.19.
6
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.恶性胸膜间皮瘤的治疗:美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 May 1;36(13):1343-1373. doi: 10.1200/JCO.2017.76.6394. Epub 2018 Jan 18.
7
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis.胸腔内热化疗对恶性胸膜间皮瘤的影响:一项系统评价和荟萃分析。
Oncotarget. 2017 Oct 19;8(59):100640-100647. doi: 10.18632/oncotarget.22062. eCollection 2017 Nov 21.
8
Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.恶性胸膜间皮瘤:调查、诊断与治疗的最新进展
Eur Respir Rev. 2016 Dec;25(142):472-486. doi: 10.1183/16000617.0063-2016.
9
Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.间皮瘤组织学亚型对监测、流行病学和最终结果数据库中预后的影响。
J Surg Res. 2015 Jun 1;196(1):23-32. doi: 10.1016/j.jss.2015.01.043. Epub 2015 Jan 29.
10
Methotrexate and gemcitabine combination chemotherapy for the treatment of malignant pleural mesothelioma.甲氨蝶呤与吉西他滨联合化疗治疗恶性胸膜间皮瘤
Mol Clin Oncol. 2013 Jul;1(4):639-642. doi: 10.3892/mco.2013.118. Epub 2013 May 10.